Institutional investors purchased a net $7.2 million shares of SNTA during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 47.46% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
D. E. SHAW & CO. LP Bought 966.0 Thousand shares of Synta Pharmaceuticals Cor...
NEW YORK STATE COMMON RETIREMENT... Bought 213.4 Thousand shares of Synta Pharmaceuticals Cor...